These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35180768)

  • 21. Rare presentation of inflammatory myofibroblastic tumor on a digit.
    West CE; Workman A; Moody T; Hosler GA
    J Cutan Pathol; 2021 Jul; 48(7):965-968. PubMed ID: 33754372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract.
    Fuehrer NE; Keeney GL; Ketterling RP; Knudson RA; Bell DA
    Arch Pathol Lab Med; 2012 Jun; 136(6):623-6. PubMed ID: 22646268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uterine inflammatory myofibroblastic tumor harboring novel NUDCD3-ROS1 and NRP2-ALK fusions: clinicopathologic features of 4 cases and literature review.
    Zhang L; Luan L; Shen L; Xue R; Huang J; Su J; Huang Y; Xu Y; Wang X; Shao Y; Ji Y; Xu C; Hou Y
    Virchows Arch; 2023 Mar; 482(3):567-580. PubMed ID: 36624188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
    Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H
    Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ALK-rearranged Mesenchymal Neoplasms: A Report of 9 cases Further Expanding the Clinicopathologic Spectrum of Emerging Kinase Fusion Positive Group of Tumors.
    Dermawan JK; DiNapoli SE; Mullaney KA; Sukhadia P; Agaram NP; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2023 Feb; 62(2):75-84. PubMed ID: 36125853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastric mesenchymal tumor with smooth muscle differentiation and echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) fusion.
    Akimoto E; Tokunaga M; Sato R; Yoshida A; Naito Y; Yamashita R; Kinoshita T; Kuwata T
    Pathol Int; 2021 Oct; 71(10):707-711. PubMed ID: 34432920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course.
    Parra-Herran C; Quick CM; Howitt BE; Dal Cin P; Quade BJ; Nucci MR
    Am J Surg Pathol; 2015 Feb; 39(2):157-68. PubMed ID: 25321329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall.
    Kerr DA; Thompson LDR; Tafe LJ; Jo VY; Neyaz A; Divakar P; Paydarfar JA; Pastel DA; Shirai K; John I; Seethala RR; Salgado CM; Deshpande V; Bridge JA; Kashofer K; Brčić I; Linos K
    Am J Surg Pathol; 2021 Dec; 45(12):1707-1719. PubMed ID: 34001695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.
    Yu L; Liu J; Lao IW; Luo Z; Wang J
    Diagn Pathol; 2016 Jul; 11(1):67. PubMed ID: 27460384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical and selected genetic reflex testing of all uterine leiomyosarcomas and STUMPs for ALK gene rearrangement may provide an effective screening tool in identifying uterine ALK-rearranged mesenchymal tumors.
    Ptáková N; Miesbauerová M; Kosťun J; Grossmann P; Šidlová H; Pavelka J; Presl J; Alaghehbandan R; Bouda J; Ondič O
    Virchows Arch; 2018 Nov; 473(5):583-590. PubMed ID: 30116888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vocal cord inflammatory myofibroblastic tumor with mucoid deposits harboring TIMP3-ALK fusion: A potential diagnostic pitfall.
    Yorita K; Togashi Y; Nakagawa H; Miyazaki K; Sakata S; Baba S; Takeuchi K; Hayashi Y; Murakami I; Kuroda N; Oda Y; Kohashi K; Yamada Y; Kiyozawa D; Michal M; Michal M
    Pathol Int; 2019 Jun; 69(6):366-371. PubMed ID: 31215130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ALK-Rearranged Epithelioid Mesenchymal Neoplasm: Expanding the Spectrum of Tyrosine Kinase-Altered Mesenchymal Tumors.
    Gestrich CK; Davis JL; Biederman L; John I; Alaggio R; Giovannoni I; Arnold MA; Shenoy A; Tchakarov A; Al-Ibraheemi A
    Mod Pathol; 2023 Dec; 36(12):100334. PubMed ID: 37726067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory myofibroblastic tumor arising from soft tissues of extremities harboring a novel CLIP2-ALK fusion.
    Ding R; Li X; Zhu XM; Song QX; Fan QH; Zhang ZH; Gong QX
    Pathol Int; 2020 Oct; 70(10):798-803. PubMed ID: 32716129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathologic features of extrapulmonary inflammatory myofibroblastic tumor].
    Li H; Shen Q; Xia Q; Shi S; Zhang R; Yu B; Ma H; Lu Z; Wang X; He Y; Zhou X; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):370-4. PubMed ID: 25208985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanocytic Myxoid Spindle Cell Tumor With ALK Rearrangement (MMySTAR): Report of 4 Cases of a Nevus Variant With Potential Diagnostic Challenge.
    Perron E; Pissaloux D; Charon Barra C; Karanian M; Lamant L; Parfait S; Alberti L; de la Fouchardière A
    Am J Surg Pathol; 2018 May; 42(5):595-603. PubMed ID: 29635259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comparative Study of Inflammatory Myofibroblastic Tumors and Tumefactive IgG4-related Inflammatory Lesions: the Relevance of IgG4 Plasma Cells.
    Chougule A; Bal A; Das A; Agarwal R; Singh N; Rao KL
    Appl Immunohistochem Mol Morphol; 2016; 24(10):721-728. PubMed ID: 26469330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases.
    Li XQ; Hisaoka M; Shi DR; Zhu XZ; Hashimoto H
    Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required.
    Pickett JL; Chou A; Andrici JA; Clarkson A; Sioson L; Sheen A; Reagh J; Najdawi F; Kim Y; Riley D; Maidens J; Nevell D; McIlroy K; Valmadre S; Gard G; Hogg R; Turchini J; Robertson G; Friedlander M; Gill AJ
    Am J Surg Pathol; 2017 Oct; 41(10):1433-1442. PubMed ID: 28731868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
    Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R
    Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study.
    Cook JR; Dehner LP; Collins MH; Ma Z; Morris SW; Coffin CM; Hill DA
    Am J Surg Pathol; 2001 Nov; 25(11):1364-71. PubMed ID: 11684952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.